Skip to content
My WebMD Sign In, Sign Up

Asthma Health Center

Font Size

FDA Panel Asks: Are Asthma Drugs Safe?

Serevent, Symbicort, Foradil Safety Focus of Triple FDA Panel Meeting

continued...

So why sell Serevent alone? GSK says it should stay on the market because doctors may wish to used a different dose of steroid than the one in the Advair combination product, or patients may need a different steroid than the one used in Advair.

But troubling questions remain for the joint FDA panel to resolve:

  • Why, if combination products are safer, does there still seem to be a significant increase in asthma-related problems with Symbicort?
  • Do LABA drugs do something to make asthma worse in some patients, or is it just that people who have LABA problems aren't getting their inflammation under control with corticosteroids?
  • Why do LABA-related adverse events seem to be more frequent in children under age 12?
  • If single-agent LABA drugs remain on the market, what is the best way to ensure patient safety?
  • Are there subgroups of patients for whom the risks of LABA drugs outweigh their benefits?

The joint panel's 27 voting members are scheduled to vote on Dec. 11, although the final questions they'll be deciding have not been announced.

1|2

When Is Your Asthma Worse?

When Is Your Asthma Worse?

Take the WebMD Asthma assessment to get Personalized Action Plan

Start Now

Today on WebMD

Distressed woman
Slideshow
Woman holding an asthma inhaler
Article
 
Get Personalized Asthma Advice
Health Check
asthma overview
Slideshow
 
Los Angeles skyline in smog
Slideshow
man in a field with allergies
Slideshow
 
Woman holding inhaler
VIDEO
Slideshow Allergy Myths and Facts
Slideshow
 
Man outdoors coughing
Article
Lung and bronchial tube graphic
Article
 
10 Worst Asthma Cities
Slideshow
runner
Article